Integra Enters Shoulder Market, Builds Upper Extremity Biz Via Ascension Purchase
This article was originally published in The Gray Sheet
Integra LifeSciences will expand its orthopedic extremity implant offerings and bolster its upper extremity business in particular while entering the shoulder market for the first time with its $65 million acquisition of Ascension Orthopedics, announced Sept. 12.
You may also be interested in...
Stryker will expand its presence in the orthopedic extremities market through its purchase of privately held French firm Memometal Technologies for $150 million up front, plus up to $12 million in milestone payments. The definitive agreement was announced June 6.
Johnson & Johnson will control a majority of the orthopedic trauma device market and double its stake in the spinal device field by acquiring Synthes for $21.3 billion under a definitive agreement announced April 27.
Modular total shoulder system gains FDA market go-ahead, announced Sept. 2. The device is designed to provide multiple shoulder arthroplasty surgery solutions in a single implant system, the company explains. It offers a bone-preserving option for patients needing total or hemi-shoulder arthroplasty, allows surgeons to select distal stems and proximal bodies that best match patients' anatomy and bone quality, and includes 26 humeral head sizing options